Diabetes technology

Is It Time to Move Beyond TIR to Time in Tight Range (TITR)? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes

Diabetes Technol TherPublished Real-world cohort study

Authors' conclusion

The data detail how CV affects the AG relationship with TIR/TITR, which has implications for CGM interpretation.

Study context

Population
Continuous glucose monitoring (CGM) users with T1D or T2D
Participants
22,006 users
Exposure
T1D vs T2D on multiple daily injections (MDI) or pumps vs T2D on basal insulin vs T2D not on insulin
Outcome
Relationship between average glucose (AG) and TIR/TITR

Main finding

As reported in the abstract

T2D groups, regardless of treatment type, had the highest TIR and TITR, with lowest coefficient of variation (CV)

23-30%

T1D had the lowest TIR and TITR, with the highest CVs

36-38%

Observational data: associations, not effects.

Original publication

Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes. Diabetes Technol Ther. Published 1 February 2024. doi:10.1089/dia.2023.0565

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.